SANDHOFF DISEASE
Clinical trials for SANDHOFF DISEASE explained in plain language.
Never miss a new study
Get alerted when new SANDHOFF DISEASE trials appear
Sign up with your email to follow new studies for SANDHOFF DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug for rare brain diseases shows promise but trial ends early
Disease control TerminatedThis study tested an oral drug called venglustat in adults and children with late-onset Tay-Sachs or Sandhoff disease, rare genetic disorders that damage the nervous system. The goal was to see if the drug could reduce harmful substances in the brain and slow disease progression.…
Matched conditions: SANDHOFF DISEASE
Phase: PHASE3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental gene therapy targets rare fatal brain diseases in kids
Disease control TerminatedThis study tested a gene therapy called AXO-AAV-GM2 in children with Tay-Sachs or Sandhoff disease, rare and fatal genetic disorders that damage the brain. The therapy aimed to deliver healthy genes to brain cells to restore a missing enzyme. The trial enrolled up to 9 children a…
Matched conditions: SANDHOFF DISEASE
Phase: PHASE1 • Sponsor: Terence Flotte • Aim: Disease control
Last updated May 12, 2026 13:41 UTC